The Journal of Urology
Volume 183, Issue 2 , Pages 598-602, February 2010

Prospective Randomized Evaluation of Periureteral Botulinum Toxin Type A Injection for Ureteral Stent Pain Reduction

Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York

Received 21 June 2009 published online 16 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional review board approval.

 For another article on a related topic see page 765.

PII: S0022-5347(09)02656-1

doi:10.1016/j.juro.2009.10.021

Refers to article:

  • Next Generation Biodegradable Ureteral Stent in a Yucatan Pig Model , 17 December 2009

    Ben H. Chew, Dirk Lange, Ryan F. Paterson, Kari Hendlin, Manoj Monga, Kenneth W. Clinkscales, Shalaby W. Shalaby, Boris A. Hadaschik
    The Journal of Urology February 2010 (Vol. 183, Issue 2, Pages 765-771)

The Journal of Urology
Volume 183, Issue 2 , Pages 598-602, February 2010

Article Tools

* Image Usage & Resolution